NCT01970592

Brief Summary

Hemiparesis, strictly defined as (muscular) weakness affecting one side of the body, is seen in three-quarters of individuals following stroke. Weakness in this population results from both neural and muscular factors which include, respectively, the ability to activate skeletal muscle as well as the force generating capacity of the muscle. The overall goal is to improve walking in persons post-stroke by training subjects with an intervention that specifically targets existing neural and muscular impairments, thereby facilitating locomotor recovery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
56

participants targeted

Target at P25-P50 for phase_2 stroke

Timeline
Completed

Started Oct 2013

Longer than P75 for phase_2 stroke

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2013

Completed
21 days until next milestone

First Submitted

Initial submission to the registry

October 22, 2013

Completed
6 days until next milestone

First Posted

Study publicly available on registry

October 28, 2013

Completed
3.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 29, 2017

Completed
1.7 years until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2019

Completed
9 months until next milestone

Results Posted

Study results publicly available

March 6, 2020

Completed
Last Updated

March 6, 2020

Status Verified

February 1, 2020

Enrollment Period

4 years

First QC Date

October 22, 2013

Results QC Date

February 20, 2020

Last Update Submit

February 20, 2020

Conditions

Keywords

exerciserehabilitationwalking

Outcome Measures

Primary Outcomes (1)

  • Gait Speed

    The speed the subject chooses to walk when instructed to walk at their "comfortable speed"

    8 weeks

Secondary Outcomes (1)

  • Muscle Strength

    8 weeks

Study Arms (1)

POWER

EXPERIMENTAL

Individuals with chronic post-stroke hemiparesis will undergo training to improve muscle power generation for 24 sessions (3 times/week) that includes both resistive and task-specific elements. Session duration will be \~90 minutes/day (inclusive of rest intervals). Training will include five distinct resistance activities aimed at improving muscle power-- each previously reported to contribute to improved walking.

Behavioral: POWER training

Interventions

POWER trainingBEHAVIORAL

Individuals with chronic post-stroke hemiparesis will undergo training to improve muscle power generation for 24 sessions (3 times/week) that includes both resistive and task-specific elements. Session duration will be \~90 minutes/day (inclusive of rest intervals). Training will include five distinct resistance activities aimed at improving muscle power-- each previously reported to contribute to improved walking

Also known as: strength training
POWER

Eligibility Criteria

Age50 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age 50-70,
  • stroke within the past 6 to 24 months,
  • residual paresis in the lower extremity (Fugl-Meyer Lower Extremity motor score \<34),
  • ability to walk without assistance and without an ankle foot orthotic (AFO) on the treadmill 30 seconds at speeds ranging from 0.3 - 0.8 m/s, and
  • provision of informed consent.
  • In addition, all subjects who meet criteria for the training portion must complete an exercise tolerance test and be cleared for participation by the study cardiologist.

You may not qualify if:

  • Unable to ambulate at least 150 feet prior to stroke, or experienced intermittent claudication while walking;
  • rating on Modified Ashworth Scale 3 at the knee or ankle;
  • limited lower extremity range of motion of the knee (passive flexion Range of Motion \[ROM\] \< 90); hip (inability to achieve neutral 0 hip extension); or ankle (inability to achieve 0 of active dorsiflexion);
  • history of congestive heart failure, unstable cardiac arrhythmias, hypertrophic cardiomyopathy, severe aortic stenosis, angina or dyspnea at rest or during activities of daily living (ADLs);
  • History of chronic obstructive pulmonary disease (COPD) or oxygen dependence;
  • Preexisting neurological disorders, dementia or previous stroke;
  • History of major head trauma;
  • Legal blindness or severe visual impairment;
  • history of significant psychiatric illness
  • Life expectancy \<1 yr.,
  • Severe arthritis or other problems that limit passive ROM;
  • post-stroke depression (PHQ-9 10),
  • History of deep vein thrombosis (DVT) or pulmonary embolism within 6 months;
  • Uncontrolled diabetes with recent diabetic coma, or frequent insulin reactions;
  • Severe hypertension with systolic \>200 mmHg and diastolic \>110 mmHg at rest;
  • +2 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ralph H. Johnson VA Medical Center, Charleston, SC

Charleston, South Carolina, 29401-5799, United States

Location

MeSH Terms

Conditions

StrokeMotor Activity

Interventions

Resistance Training

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesBehavior

Intervention Hierarchy (Ancestors)

Exercise TherapyRehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsPhysical Therapy ModalitiesPhysical Conditioning, HumanExerciseMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Limitations and Caveats

None noted

Results Point of Contact

Title
Chris Gregory
Organization
Medical University of South Carolina

Study Officials

  • Chris M Gregory, PhD

    Ralph H. Johnson VA Medical Center, Charleston, SC

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
phase 2
Allocation
NA
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
FED
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 22, 2013

First Posted

October 28, 2013

Study Start

October 1, 2013

Primary Completion

September 29, 2017

Study Completion

May 31, 2019

Last Updated

March 6, 2020

Results First Posted

March 6, 2020

Record last verified: 2020-02

Data Sharing

IPD Sharing
Will not share

Locations